ConductScience.org, home

Paper23988151

MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions.

Ylilauri M and 1 other. J Chem Inf Model, 2013. Cited by 247 papers, by iCite.

Cite this record

ConductScience Library. MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions. Papers, record 23988151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23988151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions.
PubMed
Journal
J Chem Inf Model
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
247
iCite
Relative citation ratio, by iCite
8.47
iCite
Revised in PubMed
2017-11-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ylilauri MMikko
2Pentikäinen OTOlli T

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlgorithmsMajor topic
CD18 AntigensMajor topic
Cell Adhesion MoleculesMajor topic
Cytoskeletal ProteinsMajor topic
FilaminsMajor topic
Integrin beta ChainsMajor topic
PeptidesMajor topic
Platelet Glycoprotein GPIb-IX ComplexMajor topic
Binding Sites
Humans
Ligands
Molecular Dynamics Simulation
Protein Binding
Protein Interaction Domains and Motifs
Protein Interaction Mapping
Protein Structure, Secondary
Thermodynamics

Source PubMed

Download CSV of topics

Cited by143

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 247 citations.

PMIDTitleJournalYearIn PapersSource
42947444
Synthetic Strategy to Novel Highly Functionalized Furan Analogues Bearing Imidazole-Thiazole Hybrids: Structural Characterization, Nanoparticle Formulations, Antimicrobial Evaluation, Molecular Docking Studies, and Molecular Dynamic Simulations.
Chem Biodivers2026https://conductscience.org/library/papers/42947444PubMed
42832124Computational introspection of impact of mutation A90V and A90E in DNA gyrase a of Mycobacterium tuberculosis in developing resistance against Delafloxacin.Braz J Microbiol2026https://conductscience.org/library/papers/42832124PubMed
42713227Novel bis(benzylidene)-6-methyl-2-thiouracil derivatives: design, synthesis, and molecular docking as potential antimicrobial agents against multidrug-resistant pathogenic bacteria.RSC Adv2026https://conductscience.org/library/papers/42713227PubMed
42626426Boswellia carterii Essential Oil and Constituents Alleviate Anxiety-like Behavior in Zebrafish Larvae Model.ACS Omega2026https://conductscience.org/library/papers/42626426PubMed
42511465Synthesis, Biological Evaluation, Molecular Docking and Molecular Dynamics of Substituted Thieno[2,3-d]pyrimidine Derivatives as Potential Anti-Alzheimer Agents.Int J Mol Sci2026https://conductscience.org/library/papers/42511465PubMed
42453925Therapeutic potential of Leonotis leonurus and Mentha longifolia in depression: insights from network pharmacology and molecular dynamics stimulation-based study.In Silico Pharmacol2026https://conductscience.org/library/papers/42453925PubMed
42451736Zembrin® Mitigates Reserpine-Induced Motor Dysfunction and Oxidative Stress in Parkinson's Disease: In Vivo and In Silico Analyses.Molecules2026https://conductscience.org/library/papers/42451736PubMed
42198404Visceral Leishmaniasis: Integrated In Silico Screening of Djiboutian Medicinal Plant Phytoconstituents Targeting Leishmania donovani and Leishmania infantum.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198404PubMed
42197128Phytochemical Profiling of Mulberry Diels-Alder Adducts as Selective Butyrylcholinesterase Inhibitors: In Vitro Activity, Molecular Docking, and Molecular Dynamics Simulation.Molecules2026https://conductscience.org/library/papers/42197128PubMed
42193088Natural Products in Epilepsy Treatment: From Traditional Medicine Towards Computational Drug Discovery.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42193088PubMed
42165191Anticonvulsant Potential and Network Pharmacology Analysis of Pimenta dioica (L.) Merr.Chem Biodivers2026https://conductscience.org/library/papers/42165191PubMed
42156812Comparative insecticidal efficacy and biochemical impact of nano-encapsulated citronella and geranium essential oils against Spodoptera littoralis (Lepidoptera: Noctuidae).Sci Rep2026https://conductscience.org/library/papers/42156812PubMed
42005957Molecular mechanisms underlying enhanced ACE-2-RBD stability in SARS-CoV-2 variants: The impact of key SARS-CoV-2 RBD mutations.Comput Struct Biotechnol Rep2025https://conductscience.org/library/papers/42005957PubMed
41977480Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/41977480PubMed
41974769Synthesis, antioxidant and antimicrobial activities, molecular docking study of new pyrimidine derivatives.Sci Rep2026https://conductscience.org/library/papers/41974769PubMed
41963607iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.Nat Metab2026https://conductscience.org/library/papers/41963607PubMed
41944966Mechanistic Insights into Bergapten by Modulation of Filamin A and GSK3β in STZ Induced Alzheimer's Disease: An Integrated In Silico, In Vitro and In Vivo Study.Neurochem Res2026https://conductscience.org/library/papers/41944966PubMed
41828834Computational and Molecular Dynamics Insights into the Antithrombotic Mechanism of Triterpenes Derived from Melaleuca bracteata var. Revolution Gold (Myrtaceae).Molecules2026https://conductscience.org/library/papers/41828834PubMed
41820321Multidimensional Data-Driven Mechanistic Insights into Anle Tablets for Depression Treatment through Molecular Docking and Dynamics.Curr Pharm Des2026https://conductscience.org/library/papers/41820321PubMed
41751761Identification of Enhanced Cyclooxygenase-2 (COX-2) Inhibitors Beyond Curcumin Through Virtual Screening to Target Inflammation-Related Metabolic Complications.Int J Mol Sci2026https://conductscience.org/library/papers/41751761PubMed

See all 143 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FBLIM154751PubTator's text mininghttps://conductscience.org/library/genes/54751NCBI Gene
FLNA2316PubTator's text mininghttps://conductscience.org/library/genes/2316NCBI Gene
FLNC2318PubTator's text mininghttps://conductscience.org/library/genes/2318NCBI Gene
GP1BA2811PubTator's text mininghttps://conductscience.org/library/genes/2811NCBI Gene
ITGB23689PubTator's text mininghttps://conductscience.org/library/genes/3689NCBI Gene
ITGB73695PubTator's text mininghttps://conductscience.org/library/genes/3695NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23988151

GET https://conductscience.org/api/papers/v1/23988151/cited_by?page=2